Abstract: Provided is a heat-exchanging and mixing device and a solution transport and cooling unit which are capable of efficiently performing heat transfer with respect to a heat-exchange target, while stirring and mixing the heat-exchange target, to obtain an advantageous effect of being able to significantly hinder accumulation of a solid content in the solution transport and cooling unit. The heat-exchanging and mixing device comprises a heat exchanger tube and a spiral mixing member having a width approximately equal to an inner diameter of the heat exchanger tube and disposed inside the heat exchanger tube. The spiral mixing member is comprised of a strip-shaped member having an inter-slit region.

Abstract: Provided is a heat-exchanging and mixing device and a solution transport and cooling unit which are capable of efficiently performing heat transfer with respect to a heat-exchange target, while stirring and mixing the heat-exchange target, to obtain an advantageous effect of being able to significantly hinder accumulation of a solid content in the solution transport and cooling unit. The heat-exchanging and mixing device comprises a heat exchanger tube and a spiral mixing member having a width approximately equal to an inner diameter of the heat exchanger tube and disposed inside the heat exchanger tube. The spiral mixing member is comprised of a strip-shaped member having an inter-slit region.

Abstract: To provide a solution conveying and cooling apparatus that enables removal of a deposit of solid material, or a fouling deposit, inside the apparatus with extremely simple work equipment by fewer on-site workers in a short tune without any dangerous work such as hydroblasting. The solution conveying and cooling apparatus has a rigid outer tube for a cooling medium and a plurality of rigid outer tubes for solution arranged parallel to each other inside the rigid outer tube for a cooling medium. A thin inner tube is disposed inside each of the rigid outer tubes for solution, this thin inner tube having an outer diameter smaller than an inner diameter of the rigid outer tube for solution at normal temperature and pressure, and expanding by an increase in at least one of temperature and pressure of a solution conveyed and as a result contacting with an inner surface of the rigid outer tube for solution that is cooled by the cooling medium.

Abstract: Anti-Fas antibodies which are cross-reactive with mouse and human Fas and are useful in the treatment of conditions attributable to abnormalities in the Fas/Fas ligand system.

Abstract: Anti-Fas antibodies which are cross-reactive with mouse and human Fas and are useful in the treatment of conditions attributable to abnormalities in the Fas/Fas ligand system.

Abstract: Anti-Fas antibodies which are cross-reactive with mouse and human Fas and are useful in the treatment of conditions attributable to abnormalities in the Fas/Fas ligand system.

Abstract: The present invention relates to a novel antibacterial compound obtainable from the genus Alteromonas and which shares structural similarity with the pseudomonic acids.

Abstract: A series of new compounds, called "the phomactins" is provided and may be isolated from the culture broth of fungi of the genus Phoma. especially Phomas sp. SANK 11486 (No. FERM BP-2598). These compounds are platelet activating factor antagonists and may be used for the treatment of disorders for which known such agents may also be used.

Abstract: The present invention relates to a novel antibacterial compound obtainable from the genus Alteromonas and which shares structural similarity with the pseudomonic acids.

Abstract: 5-Amino-1-(hydroxymethyl)cyclopentane-1,2,3,4-tetraol and 2-amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5, 6-triol, which have the ability to inhibit the activity of sugar hydrolases, especially .beta.-glucosidase and sucrase and can thus be used for the treatment and prophylaxis of tumorous conditions, AIDS, diabetes and obesity, can be prepared by hydrolysis of trehazolin. 2-Amino-4-(hydroxymethyl)-3a,5,6,6a-tetrahydro-4H-cyclopent[d]oxazole-4,5, 6-triol can also be prepared by fermentation using newly isolated strains Micromonospora sp. SANK 62390, FERM BP-3521 and Amycolatopsis sp. SANK 60791, FERM BP-3513.

Abstract: A series of new compounds, called "the phomactins" is provided and may be isolated from the culture broth of fungi of the genus Phoma, especially Phoma sp. SANK 11486 (No. FERM BP-2598). These compounds are platelet activating factor antagonists and may be used for the treatment of disorders for which known such agents may also be used.